MAOA and schizophrenia: Apart from the irreversible MAO inhibitors, another useful agent is moclobemide (a reversible MAO-A inhibitor) that could improve negative, depressive, and general symptoms in subjects with schizophrenia associated with prominent negative symptoms (Silver et al., 1999).